Anne Kerneur

Partner

Paris + 33.1.56.59.39.39

Connect:

Share

Anne Kerneur's practice focuses on venture capital and capital markets. For more than a decade, she has represented technology, life sciences, and other growth companies, as well as the venture firms and industrial investors that fund them, at every stage of development, from entrepreneurial start-ups to public companies. Anne also regularly advises public companies on governance and executive compensation matters.

Anne's experience includes advising high-growth companies in connection with their financing rounds such as Lithium de France, Arverne Group, Indy.fr, Ankorstore, Shippeo, Akeneo, and TreeFrog Therapeutics and venture capital investors or strategic investors such as TilT Capital, Alven, Creadev, ETF, Hi Inov, Idinvest/Eurazeo, Quadrant Management, Ring Capital, Sofinnova Partners, Seventure, and BNPP.

Illustrative transactions in which Anne acted as lead or co-lead lawyer includes: the €44 million series B financing of Lithium de France led by Equinor and Hydro, the €40 million financing round of EODEV led by TilT Capital, the €250 million financing round of Ankorstore led by Bond and Tiger, and the €35 million financing round of Selency led by Creadev. Anne also advised Arverne Group in its IPO on Euronext in Paris by way of DeSPAC and its €130 million private placement, Cellectis on its US$20 million public offering on Nasdaq, and Integragen in the successful public tender offer of shares by OncoDNA. She also worked on the IPO of Criteo on Nasdaq and the recent IPO of EUROAPI on the main French market.

Experience

  • Sanofi to separate its consumer healthcare business, OpellaJones Day acted as securities law counsel in the separation of Opella, Sanofi's consumer healthcare business, and the sale of a 50% controlling stake to CD&R.
  • Seventure invests in ekstereJones Day advised Seventure Partners in the €2.4 million financing of ekstere, France's first online platform for buying and selling used bikes.
  • CARMAT completes €9.7 million share capital increaseJones Day represented CARMAT SA, the designer and developer of the world's most advanced total artificial heart listed on Euronext Growth Paris, in connection with its €9.7 million share capital increase without preferential subscription rights reserved to financial investors and retail.
  • ETF Partners participates in €15 million financing of HubcycleJones Day represented ETF Partners in the €15 million financing of Hubcycle, a French groundbreaking company revolutionizing the upcycling of food by-product.
  • Affiliates of Centre Lane Partners acquire substantially all of the assets of Hardinge Inc. and its subsidiaries, including the Kellenberger, USACH, SuperPrecision, and Workholding business linesJones Day advised affiliates of Centre Lane Partners in the acquisition of substantially all of the assets of Hardinge Inc. and its debtor subsidiaries, a global leader and provider of advanced machine tool, manufacturing and workholding solutions, as part of chapter 11 proceedings in the United States Bankruptcy Court for the District of Delaware.
  • BNP Paribas participates in $640 million Series B financing of Mistral AIJones Day advised BNP Paribas in the $640 million Series B financing of Mistral AI, an AI-powered solutions company, including data entry systems and large language models.
  • TiLT Capital Partners leads €46 million financing of EODevJones Day advised TiLT Capital Partners SAS in leading the €46 million financing of EODev, along with Supernova Invest, CapHorn, Pulse (CMA-CGM), and the existing shareholders of EODev, to strengthen its leading position in the hydrogen fuel cell power generators market by financing its investment program, the expansion of its product range, and the acceleration of its commercial development.
  • Arverne Group combines with Transition to publicly list on Euronext Paris the future French leader in geothermal and low-carbon lithium to drive energy transitionJones Day advised Arverne Group SAS, a French company ("Arverne"), in its business combination with Euronext listed Transition SA to create the future French leader in geothermal and low-carbon lithium production.
  • Lithium de France raises €44 million in Series B financingJones Day advised Lithium de France, first independent French operator of geothermal heat and lithium, in connection with its €44 million Series B financing subscribed by its main shareholders, Arverne Group, Equinor Ventures AS, and a new investor Hydro Energi Invest AS.
  • Seventure leads €12 million Series A funding round of Citalid Cybersécurité SASJones Day advised Seventure Partners as lead investor in the €12 million Series A financing round of Citalid Cybersécurité SAS, a France-based cyber risks management and decision support platform.
  • TiLT Capital Partners participates in €9.8 million Series A financing of Watt & WellJones Day advised Tilt Capital Partners SAS in connection with the €9.8 million Series A financing of Watt & Well, a designer and manufacturer of electronic power equipment, along with BNP Paribas Développement and Bpifrance.
  • Creadev and Temasek invest in InnovafeedJones Day advised Creadev SAS and Temasek, investors in the $250 million Series D financing of Innovafeed, a leader in the production of insects (Hermetia Illucens) for animal and plant nutrition.
  • Ring invests €6 million in LeHibouJones Day advised Ring Capital in the €6 million financing of LeHibou, an intermediation platform between IT freelancers and large companies.
  • Seventure leads €7 million Series A financing round of JolimoiJones Day advised Seventure Partners as lead investor in the €7 million Series A financing round of Jolimoi, a French start-up company engaged in the business of direct and e-commerce sale of multi-brand beauty and lifestyle products using social selling and the development of self-service (SaaS) technological solutions for clients using social selling in the beauty domain.
  • Hi Inov, Omnes, and Swen Capital Partners invest in SkillupJones Day represented Hi Inov, Omnes, and Swen Capital Partners in connection with the €8 million round of financing along with existing investors Global Founders Capital and Kerala in Skillup, a human resource talent management SaaS.
  • Creadev leads €35 million investment in SelencyJones Day represented Creadev as lead investor with Accel in the €35 million Series B round of financing of Selency, a Paris-based impact e-commerce platform and Europe's leading marketplace for second-hand furniture and home decor.
  • Sofinnova leads €15 million Series A financing round of GFBiochemicalsJones Day advised Sofinnova Partners, as lead investor, with participation from Sparta Capital, in the €15 million Series A financing round of GFBiochemicals to accelerate GFBiochemicals' mission to end chemical pollution by helping fast moving consumer goods (FMCG) and industrial companies transition away from using toxic, environmentally harmful petrochemicals in everyday products.
  • Hi Inov participates in €150 million Series C financing round of DeepkiJones Day advised Hi Inov in connection with its participation in the €150 million Series C financing round of Deepki, a French start-up company operating an ESG data intelligence platform for the real estate sector, led by One Peak and Highland Europe.
  • Quadrant Management participates in $45 million Series C financing round of WandercraftJones Day advised Quadrant Management in connection with its participation in a $45 million Series C financing round of Wandercraft, a leading healthtech company in dynamic robotic and exoskeleton technology.
  • Ankorstore raises €250 million in Series C financing roundJones Day advised Ankorstore, a French company developing and operating marketplaces whose purpose is to connect brands and designers with professionals, notably through digital platforms, in connection with its €250 million Series C round of financing led by BOND and Tiger Global.
    • View All

    September 18-20, 2023 Speaking Engagements

    Jones Day lawyers to attend IPEM 2023

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.